International Journal of Infection

Published by: Kowsar

The Prevalence of HBsAg, Anti-HCV, and Anti-HBc in Patients With β-Thalassemia Referred to Blood Banking Department of Ghaem Hospital in Mashhad, Northeast of Iran

Fatemeh Abrishami 1 and Ali Golshan 2 , *
Authors Information
1 Department of Hematology, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Department of Oral and Maxillofacial Pathology, Dental School, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • International Journal of Infection: July 2018, 5 (3); e81518
  • Published Online: July 10, 2018
  • Article Type: Research Article
  • Received: February 1, 2017
  • Revised: February 20, 2017
  • Accepted: February 22, 2017
  • DOI: 10.5812/iji.81518

To Cite: Abrishami F, Golshan A. The Prevalence of HBsAg, Anti-HCV, and Anti-HBc in Patients With β-Thalassemia Referred to Blood Banking Department of Ghaem Hospital in Mashhad, Northeast of Iran, Int J Infect. 2018 ;5(3):e81518. doi: 10.5812/iji.81518.

Abstract
Copyright © 2018, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Ahmed Kiani R, Anwar M, Waheed U, Asad MJ, Abbasi S, Abbas Zaheer H. Epidemiology of Transfusion Transmitted Infection among Patients with beta-Thalassaemia Major in Pakistan. J Blood Transfus. 2016;2016:8135649. doi: 10.1155/2016/8135649. [PubMed: 27559490]. [PubMed Central: PMC4983372].
  • 2. Mahmoud RA, El-Mazary AA, Khodeary A. Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt. Adv Hematol. 2016;2016:9032627. doi: 10.1155/2016/9032627. [PubMed: 26989417]. [PubMed Central: PMC4773519].
  • 3. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007;28(10):1516-9. [PubMed: 17914511].
  • 4. Alavian SM. Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province. Int J Infec. 2015;2(2). doi: 10.17795/iji-17937.
  • 5. Ebrahimzadeh A, Azarkar Z, Ziaee M, Sharifzadeh G, Bijari B. Prevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014. International Journal of Infection. 2016;3(1). doi: 10.17795/iji-34102.
  • 6. El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin. 2009;33(sup1):S14-20.
  • 7. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Ahmadi AB, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009;9(3):211-23.
  • 8. Brown RS, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transplantation. 2003;9(11):S10-3. doi: 10.1053/jlts.2003.50244.
  • 9. Angelucci E, Pilo F. Treatment of hepatitis C in patients with thalassemia. Haematologica. 2008;93(8):1121-3. doi: 10.3324/haematol.13500. [PubMed: 18669974].
  • 10. Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon. 2007;7(1):3-5.
  • 11. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005;8(2):84-90.
  • 12. Agarwal MB, Malkan GH, Bhave AA, Vishwanathan C, Billa V, Dube SR, et al. Antibody to hepatitis-C virus in multi-transfused thalassaemics--Indian experience. J Assoc Physicians India. 1993;41(4):195-7. [PubMed: 8270554].
  • 13. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: Epidemiology, prevention, and management. J Pediatr HematolOncol. 2007;29(4):233-8. doi: 10.1097/MPH.0b013e3180437e02.
  • 14. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006;9(4):319-23. [PubMed: 17061602].
  • 15. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. J Paediatr Child Health. 2001;37(6):564-6. [PubMed: 11903836].
  • 16. Mishra D, Pensi T. Transfusion associated hepatitis C in multi-transfused thalassemic children. Indian Pediatr. 2004;41(3):287-8.
  • 17. Chakrabarty P, Rudra S, Hossain MA. Prevalence of HBV and HCV among the multi-transfused beta thalassemic major patients in a day care centre of blood transfusion department of Mymensingh Medical College Hospital. Mymensingh Med J. 2014;23(2):235-41.
  • 18. Irshad M, Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J gastroenterol. 2002;21(5):183-4.
  • 19. Rahman M, Lodhi Y. Prospects & future of conservative management of beta thalassemia major in a developing country. Pakistan J Med Sci. 2004;20:105-12.
  • 20. al-Fuzae L, Aboolbacker KC, al-Saleh Q. beta-Thalassaemia major in Kuwait. J Trop Pediatr. 1998;44(5):311-2. doi: 10.1093/tropej/44.5.311. [PubMed: 9819498].
  • 21. El Gohary A, Hassan A, Nooman Z, Lavanchy D, Mayerat C, El Ayat A, et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Tropica. 1995;59(2):155-61. doi: 10.1016/0001-706x(95)00075-p.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments